Scinai Immunotherapeutics Ltd's Comment on Sales, Marketing and Customers
The company operates in two primary markets: therapeutic development and contract development and manufacturing organization (CDMO) services. It provides services under contracts established on commercially acceptable terms, adhering to specified quality standards and timelines. Additionally, the company relies on third parties and collaborators for the development, commercialization, and marketing of its product candidates.
Scinai Immunotherapeutics Ltd’s Comment on Sales, Marketing and Customers
The company operates in two primary markets: therapeutic development and contract development and manufacturing organization (CDMO) services. It provides services under contracts established on commercially acceptable terms, adhering to specified quality standards and timelines. Additionally, the company relies on third parties and collaborators for the development, commercialization, and marketing of its product candidates.
Sources:
Scinai Immunotherapeutics Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Scinai Immunotherapeutics Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Scinai Immunotherapeutics Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
